Acompanhe as Notícias da Recifes

After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that treatment is working. A recent real-world study indicates that reaching a PSA level below 0.2 ng/mL is an indicator of improved patient survival. The

Câncer colorretal deve causar 635 mil mortes e perdas bilionárias no Brasil até 2030 Adobe Stock O Ministério da Saúde incluiu na tabela de procedimentos do Sistema Único de Saúde (SUS) o Teste Imunoquímico Fecal (FIT) para rastreamento de câncer colorretal. O exame será destinad

Médicos discutem os principais avanços apresentados na Asco 2026, com foco em alguns dos tumores mais comuns entre os brasileiros

The American College of Surgeons (ACS) Commission on Cancer (CoC) has introduced a new rural accreditation category to expand access to high-quality cancer care in rural communities, where long travel times and specialist shortages often limit care.

New research from Keele University and the University of Aberdeen has found that men with cardiovascular disease are at higher risk of cancer and death from cancer than women. The study found this pattern across all cancer subtypes, with lung cancer and colorectal cancers account

Hepatitis C remains a major cause of liver cirrhosis and liver cancer worldwide. Although highly effective antiviral medicines can cure most infections, many people remain undiagnosed or untreated because health care systems often fail to reach those at greatest risk.

Researchers at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center are zeroing in on less toxic and more targeted strategies to combat Ewing sarcoma, an aggressive and rare pediatric cancer that develops in the bones and soft tissues.

The need for more effective lung cancer treatments is paramount, as the disease remains a leading cause of cancer deaths in the United States. New findings by a research team from the Stony Brook Cancer Center highlight a novel therapeutic shown to be highly effective in reducing

O câncer de pulmão é uma doença silenciosa, e segundo o oncologista Igor Morbeck, membro do Comitê Científico do Instituto Lado a Lado pela Vida, entre 70% e 80% dos cânceres de pulmão no mundo são diagnosticados em fase totalmente avançada ou em metástase. No Brasil, não é difer

Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a Phase III clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and inves

Glioblastoma remains one of the deadliest cancers, with limited treatment advances and tumors that often resist radiation and chemotherapy. New research from The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Insti

Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ domain of the GIPC1 protein, which helps different types of cancer, including pancreatic cancer, grow and resist treatment. In laboratory stud